Similar articles

• Rationalizing the evolution of EAL domain-based cyclic di-GMP-specific phosphodiesterases.

  Römling U. Römling U. J Bacteriol. 2009 Aug;191(15):4697-700. doi: 10.1128/JB.00651-09. Epub 2009 May 29. J Bacteriol. 2009. PMID: 19482927 Free PMC article. No abstract available.
• Hormonal regulation of cyclic nucleotide phosphodiesterases.

  Conti M, Jin SL, Monaco L, Repaske DR, Swinnen JV. Conti M, et al. Endocr Rev. 1991 Aug;12(3):218-34. doi: 10.1210/edrv-12-3-218. Endocr Rev. 1991. PMID: 1657587 Review. No abstract available.
• Backbone 1H, 13C, and 15N resonance assignment of the 46 kDa dimeric GAF A domain of phosphodiesterase 5.

  Sekharan MR, Rajagopal P, Klevit RE. Sekharan MR, et al. J Biomol NMR. 2005 Sep;33(1):75. doi: 10.1007/s10858-005-1615-5. J Biomol NMR. 2005. PMID: 16222566 No abstract available.
• [Role of cyclic GMP in visnal process-activation of cyclic GMP phosphodiesterase by light and ATP (author's transl)].

  Miki N. Miki N. Tanpakushitsu Kakusan Koso. 1976 Aug 1;21(8):605-11. Tanpakushitsu Kakusan Koso. 1976. PMID: 9667 Japanese. No abstract available.
• Multiplicity within cyclic nucleotide phosphodiesterases.

  Rybalkin SD, Beavo JA. Rybalkin SD, et al. Biochem Soc Trans. 1996 Nov;24(4):1005-9. doi: 10.1042/bst0241005. Biochem Soc Trans. 1996. PMID: 8968501 Review. No abstract available.